U.S. Markets open in 5 hrs 47 mins

The internet hilariously reacts to Trump's Space Force launch

The White House has officially laid the groundwork for Space Force, the Trump administration’s efforts to expand the U.S. armed forces into outer space.

Vice President Mike Pence announced the plan at the Pentagon on Thursday and gave a 2020 deadline to launch what will become the sixth branch of the U.S. military.

"Now the time has come to write the next great chapter in the history of our armed forces, to prepare for the next battlefield where America's best and bravest will be called to deter and defeat a new generation of threats to our people, to our nation," said Pence. "The time has come to establish the United States Space Force."

President Trump was elated with the announcement, as he expressed on Twitter.

Others were a bit more apprehensive about the proposal, and they provided plenty of space-related jokes, including a few Hollywood-inspired quips.

  • Business
    Investing.com

    Dollar Firm as Pessimism over Global Growth hits Risk Sentiment

    Investing.com - The dollar was trading near two-week highs against a basket of its rivals on Tuesday as concerns over the outlook for the global economy underpinned investor demand for safe haven assets. The U.S. dollar index, which measures the greenback's strength against a basket of six major currencies, was up 0.14% to 96.12, the most since Jan. 4 by 02 50 AM ET (07:50 AM GMT). The International Monetary Fund cut its 2019 and 2020 global growth forecasts on Monday, citing a bigger-than-expected slowdown in China and the euro zone and said failure to resolve trade tensions could further destabilize a slowing global economy.

  • Company Chairman, Wife Cut Stake as Hong Kong Stock Plunged 89%
    Business
    Bloomberg

    Company Chairman, Wife Cut Stake as Hong Kong Stock Plunged 89%

    Shum Tin Ching and his wife Wang Xinmei sold 93.6 million shares of Jiayuan International Group Ltd. on Jan. 17 at an average of HK$2.7611 apiece -- about a 79 percent discount from the previous day's close -- according to a Hong Kong exchange filing. Jiayuan tumbled as much as 24 percent before shares were suspended. Stocks that plunged last week with Jiayuan also sank, with Sunshine 100 China Holdings Ltd. falling as much as 13 percent and Rentian Technology Holdings Ltd. retreating 9.1 percent.

  • Did Pitney Bowes Inc. (NYSE:PBI) Insiders Buy Up More Shares?
    Business
    Simply Wall St.

    Did Pitney Bowes Inc. (NYSE:PBI) Insiders Buy Up More Shares?

    Unfortunately, there are also plenty of examples of share prices declining precipitously after insiders have sold shares. Do Insider Transactions Matter? It is perfectly legal for company insiders, including board members, to buy and sell stock in a company.

  • Dow futures drop nearly 200 points as growth, trade worries fester
    Business
    MarketWatch

    Dow futures drop nearly 200 points as growth, trade worries fester

    U.S. stock futures indicated losses for Wall Street on Tuesday, as fresh concerns over the state of the global economy and grade were set to greet investors returning from the long holiday weekend. Dow Jones Industrial Average futures (YMH9) fell 193 points, or 0.8%, to 24,495, while S&P 500 futures (ESH9) dropped 20.85 points, or 0.8%, to 2,650.50. Nasdaq-100 (NQH9) futures fell 68.25 points, or 1%, to 6,725.

  • Alibaba Earnings: What to Expect Amid China's Economic Slowdown
    Business
    Motley Fool

    Alibaba Earnings: What to Expect Amid China's Economic Slowdown

    A slowdown in Alibaba's earnings and revenue is coming The fiscal third quarter is an important one for Alibaba because it includes its annual Singles Day sales extravaganza, which takes place on Nov. 11. It's the largest single day of sales for the company, and revenues have grown significantly every year. In 2018, the event again set a new record for gross merchandise value (GMV) -- $30.8 billion -- and sales grew 27% year over year.

  • Top Marijuana Stocks on the NASDAQ
    Business
    Investopedia

    Top Marijuana Stocks on the NASDAQ

    The cannabis companies on the NASDAQ reflect this, with the majority of them operating in the biotech area of the industry. Here are the NASDAQ-listed marijuana stocks, in alphabetical order, as of Oct. 9, 2018, with a breakdown of their total returns. The NASDAQ was the first electronic exchange and has long been synonymous with technology and biotechnology.

  • Implied Volatility Surging for Chesapeake Energy (CHK) Stock Options
    Business
    Zacks

    Implied Volatility Surging for Chesapeake Energy (CHK) Stock Options

    Options with high levels of implied volatility suggest that investors in the underlying stocks are expecting a big move in one direction or the other. It could also mean there is an event coming up soon that may cause a big rally or a huge sell-off. However, implied volatility is only one piece of the puzzle when putting together an options trading strategy.

  • AMD Takes a Crack at the Chromebook Market
    Business
    Motley Fool

    AMD Takes a Crack at the Chromebook Market

    Instead, AMD is looking to grow its share in the notebook PC market by expanding beyond Windows-based computers and offering products for low-cost Chromebooks, which run on Google's Chrome operating system. Let's take a closer look at the opportunity here for AMD. How big is the Chromebook chip market?

  • Business
    MoneyShow

    Top Picks 2019- General Electric GE

    The stock market correction took GE down even further. It is possible that GE will go lower. If so, I doubt that any additional decline will be very large.

  • Democrat who opposed Pelosi for speaker is blocked from a seat on the judiciary committee
    Politics
    Fox Business Videos

    Democrat who opposed Pelosi for speaker is blocked from a seat on the judiciary committee

    New Jersey Democrat Rep. Jeff Van Drew says he did not vote Nancy Pelosi for speaker because his constituents wanted someone with new ideas.

  • Square's Newest Product Is Genius
    Business
    Motley Fool

    Square's Newest Product Is Genius

    The Square Card, a free business debit Mastercard for Square merchants, gives its users access to funds as soon as they make a sale through their Square card reader. It's the latest move by Square to provide more banking services for its users. The Square Card is a very similar product, but for business expenses, and it could be an even bigger success for Square's business.

  • United Tech Needs Positive Earnings to Gain Momemtum
    Business
    Investopedia

    United Tech Needs Positive Earnings to Gain Momemtum

    Otis Elevators will be separately traded, as will Carrier, which makes air conditioning systems and fire and security products. United Technologies stock closed last week at $113.90, up 7% so far in 2019 but in bear market territory at 21% below its all-time intraday high of $144.15 set on Sept. The stock set its 2018 low of $100.48 on Dec. 26 and is up 13.4% since then.

  • Netflix Loses Ground On Sales Miss
    Business
    Investor's Business Daily Video

    Netflix Loses Ground On Sales Miss

    Netflix Loses Ground On Sales Miss

  • Would Pfizer Shareholders Win With an Acquisition of Amarin?
    Business
    Motley Fool

    Would Pfizer Shareholders Win With an Acquisition of Amarin?

    Arguments against a deal Probably the biggest argument against Pfizer buying Amarin is that the drugmaker really doesn't have to make a deal right now. Pfizer's pipeline is as strong as it's been in a long time. The company's top products, including blood thinner Eliquis and breast cancer drug Ibrance, continue to generate solid sales growth.

  • IBM earnings: Emerging tech expected to account for half of sales as revenue declines
    Business
    MarketWatch

    IBM earnings: Emerging tech expected to account for half of sales as revenue declines

    International Business Machines Corp. is looking at a second straight quarter of revenue declines, but hopes to turn the corner to have half of its revenue derived from emerging technologies rather than from legacy mainframes. IBM said its “strategic imperatives” businesses — that is, cloud, analytics, mobile, social and security — generated $39.5 billion in revenue and represented 49% of total IBM revenue over the previous 12 months through the third quarter. Instinet analyst Jeffrey Kvaal, who has a buy rating on IBM and reduced his price target to $160, said a strong dollar still presents a headwind for IBM and will likely continue into 2019.

  • This Might Be the Best Marijuana Stock on the Market
    Business
    Motley Fool

    This Might Be the Best Marijuana Stock on the Market

    In fact, I think that on an overall basis this might be the best marijuana stock on the market. In 2017, the alcoholic beverage maker made its first investment in Canadian marijuana producer Canopy Growth (NYSE: CGC). Constellation Brands believes that the global retail cannabis market will exceed $200 billion within the next 15 years.

  • These 4 Marijuana Stocks Could Follow Tilray Lower
    Business
    Motley Fool

    These 4 Marijuana Stocks Could Follow Tilray Lower

    The cannabis industry has been a hotbed of investor interest over the past year, and marijuana stocks have seen dramatic levels of volatility. The ups and downs in the share prices of many of the best-known cannabis companies have shown just how speculative the space is right now, but it's also critically important to understand some of the mechanics involved with these young companies and how their shares trade. On Jan. 15, shares of Tilray (NASDAQ: TLRY) plunged 17% as early investors in the marijuana producer got their first chance to sell shares into the public market.

  • 3 Top Semiconductor Stocks to Buy in 2019
    Business
    Motley Fool

    3 Top Semiconductor Stocks to Buy in 2019

    As a result, the stock finished the year down 1%. Nonetheless, now could be a good time to add the stock to your watchlist. Management expects revenue in 2019 to rise to $24.5 billion, another 17% increase, which should equate to even higher profits.

  • Can Celgene (CELG) Keep the Earnings Surprise Streak Alive?
    Business
    Zacks

    Can Celgene (CELG) Keep the Earnings Surprise Streak Alive?

    For the most recent quarter, Celgene was expected to post earnings of $2.24 per share, but it reported $2.29 per share instead, representing a surprise of 2.23%. For the previous quarter, the consensus estimate was $2.10 per share, while it actually produced $2.16 per share, a surprise of 2.86%. Price and EPS Surprise For Celgene, estimates have been trending higher, thanks in part to this earnings surprise history.

  • A Plea to Aurora Cannabis: Stop Diluting Your Shareholders
    Business
    Motley Fool

    A Plea to Aurora Cannabis: Stop Diluting Your Shareholders

    In many ways Aurora Cannabis has the makings of a cannabis giant... if not for its ongoing dilution. The rise of bought-deal offerings, the pot industry's "necessary evil" Since Canadian pot stocks have very limited access to nondilutive forms of financing, nearly all have turned to bought-deal offerings to raise capital.

  • Dow Jones Futures: Netflix, Microsoft Lead 5 Top Stocks Nearing Buy Points
    Business
    Investor's Business Daily

    Dow Jones Futures: Netflix, Microsoft Lead 5 Top Stocks Nearing Buy Points

    Dow Jones futures fell late Monday, along with S&P 500 futures and Nasdaq futures, after U.S. stock markets were closed in observance of the Martin Luther King holiday. The stock market rally powered higher last week, with the Dow Jones, S&P 500 index and Nasdaq composite all reclaiming their 50-day lines. Microsoft, Netflix, Adobe, Salesforce.com and Visa are large-cap stock worth watching.

  • Top Ranked Value Stocks to Buy for January 21st
    Business
    Zacks

    Top Ranked Value Stocks to Buy for January 21st

    Here are three stocks with buy rank and strong value characteristics for investors to consider today, January 21st: UnitedHealth Group Incorporated (UNH): This diversified health company has a Zacks Rank #2 (Buy), and seen the Zacks Consensus Estimate for its current year earnings rising 0.3% over the last 60 days. UnitedHealth Group Incorporated Price and Consensus UnitedHealth Group Incorporated price-consensus-chart | UnitedHealth Group Incorporated Quote UnitedHealth has a price-to-earnings ratio (P/E) of 18.15 compared with 33.60 for the industry.

  • AbbVie's Imbruvica Fails in Phase III Pancreatic Cancer Study
    Business
    Zacks

    AbbVie's Imbruvica Fails in Phase III Pancreatic Cancer Study

    AbbVie Inc. ABBV announced that a combination regimen of its blockbuster cancer drug, Imbruvica (ibrutinib), failed in a phase III study, evaluating it for the treatment of metastatic pancreatic adenocarcinoma, one of the most aggressive and deadliest forms of cancer. The phase III RESOLVE study investigated the efficacy of Imbruvica in combination with chemotherapy agents nab-paclitaxel and gemcitabine compared with placebo in combination with these chemotherapy agents for first-line treatment of patients suffering metastatic pancreatic cancer.

  • 3 Stocks to Buy and Hold for Decades
    Business
    Motley Fool

    3 Stocks to Buy and Hold for Decades

    Microsoft (NASDAQ: MSFT), Mastercard (NYSE: MA), and Alibaba (NYSE: BABA) are very different businesses, but they do share one thing in common: the potential to reward investors with long-term growth. Three Motley Fool contributors weigh in on how managing mountains of data, the war on cash, and increasingly wealthier emerging markets could lift these stocks in the coming decades. Information is increasingly being distributed across devices, rather than constrained within silos, and Microsoft's solutions, including cloud computing, artificial intelligence/machine learning, and unified experience -- such as entertainment-anywhere initiatives -- could make this already giant company even bigger in the coming decades.

  • Is Aphria a Buy?
    Business
    Motley Fool

    Is Aphria a Buy?

    Potential rewards While there certainly are several real risks for Aphria, the stock holds the potential to deliver big rewards to patient investors as well. Starting on Aphria's home front, the Canadian recreational marijuana market is just getting started. Naysayers predicting weaker-than-expected demand for recreational marijuana have been proven wrong so far.